Miriam Knoll
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Miriam Knoll
Jun 21, 2024, 12:21 |
Blog
Fumiko Ladd Chino: We're going to usher in a new era of multidisciplinary leadership!
Fumiko Ladd Chino shared on X/Twitter: "Of note, MD Anderson Cancer Center will have 2 RadOnc…
Jun 16, 2024, 16:07 |
Blog
Fumiko Ladd Chino: We're going to usher in a new era of multidisciplinary leadership!
Fumiko Ladd Chino shared one of her previous posts on X and added: "Of note,…
Jun 1, 2024, 21:18 |
Blog
Fumiko Ladd Chino: 2 phenomenal oncologists at ASCO24
Fumiko Ladd Chino shared a post on X: "Powerful in purple, 2 phenomenal oncologists at asco24.…
May 30, 2024, 02:17 |
Societies
ASCO24 Pro Tip by Miriam Knoll
Miriam Knoll shared on X: "ASCO24 Pro Tip: If you're looking for a job, scout…
Apr 17, 2024, 14:04 |
Blog
Karan Jatwani: Looking forward to advocate for our patients
Karan Jatwani, Medical Oncology Fellow at Roswell Park Comprehensive Cancer Center, shared a post by…
All:
5
Posts:
1 - 10
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube